IME Archives - BioTuesdays

Developments

Imagin Medical reports agenda for KOL virtual investor event on Oct. 29

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) reported the agenda for its KOL virtual investor event taking place on Oct. 29 at 12:00 pm ET. Presenters include Jim Hutchens, Imagin’s...

October 26, 2020

Developments

Imagin Medical selects Lighthouse Imaging as i/Blue contract manufacturer

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) selected Lighthouse Imaging as the contract manufacturer for the i/Blue Imaging System. Lighthouse is an FDA registered and ISO 13485:2016...

October 7, 2020

Developments

Imagin Medical to host KOL webcast on Oct. 29

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) will host a virtual investor event with key opinion leaders on Oct. 29 at 12:00 pm ET to highlight the potential of the company’s i/Blue...

September 29, 2020

Developments

Imagin Medical to test i/Blue Imaging System on anatomical bladder models

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) will use anatomical bladder models to confirm the i/Blue Imaging System’s simultaneous white and blue light image display. The anatomical...

July 15, 2020

Developments

Imagin Medical receives functional i/Blue Imaging Systems

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) received functional i/Blue systems from its contract design and development firm, Optel, which will be used to conduct in...

May 21, 2020

Developments

Imagin Medical supports Bladder Cancer Awareness Month

This month, Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) will be undertaking a number of efforts and activities to help raise awareness about bladder cancer. Imagin has created and will...

May 12, 2020

Developments

Imagin Medical gets additional positive physician feedback on i/Blue Imaging System

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) has continued to collect additional input on its i/Blue Imaging System from physicians in the United States and Canada. Leading urologists...

March 10, 2020

Developments

Imagin Medical successfully completes i/Blue’s design verification

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) completed design verification of its i/Blue Imaging System functional unit on schedule. i/Blue is based on advanced optics and light sensors...

January 8, 2020

Developments

Imagin Medical updates i/Blue’s functional unit development

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) provided an update on its progress towards verifying the i/Blue imaging system’s functional prototype. The company has integrated the i/Blue...

July 15, 2019

Executive Moves

Imagin Medical adds world-renowned bladder cancer expert Dr. Ashish Kamat to SAB

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) named Dr. Ashish Kamat to its scientific advisory board.

April 17, 2019

Tag - IME

Imagin Medical reports agenda for KOL virtual investor event on Oct. 29

Imagin Medical selects Lighthouse Imaging as i/Blue contract manufacturer

Imagin Medical to host KOL webcast on Oct. 29

Imagin Medical to test i/Blue Imaging System on anatomical bladder models

Imagin Medical receives functional i/Blue Imaging Systems

Imagin Medical supports Bladder Cancer Awareness Month

Imagin Medical gets additional positive physician feedback on i/Blue Imaging System

Imagin Medical successfully completes i/Blue’s design verification

Imagin Medical updates i/Blue’s functional unit development

Imagin Medical adds world-renowned bladder cancer expert Dr. Ashish Kamat to SAB

General

More